| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |